| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | prolactin receptor binding | 1.01e-08 | 7 | 84 | 4 | GO:0005148 | |
| GeneOntologyMolecularFunction | growth hormone receptor binding | 6.00e-08 | 10 | 84 | 4 | GO:0005131 | |
| GeneOntologyMolecularFunction | hormone receptor binding | 1.23e-05 | 34 | 84 | 4 | GO:0051427 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid hormone biosynthetic process | 1.54e-07 | 13 | 81 | 4 | GO:0090031 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone biosynthetic process | 8.18e-07 | 19 | 81 | 4 | GO:0046886 | |
| GeneOntologyBiologicalProcess | regulation of steroid hormone biosynthetic process | 2.21e-06 | 24 | 81 | 4 | GO:0090030 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway | 3.09e-06 | 26 | 81 | 4 | GO:0060396 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone metabolic process | 3.09e-06 | 26 | 81 | 4 | GO:0032352 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 3.21e-06 | 58 | 81 | 5 | GO:0032350 | |
| GeneOntologyBiologicalProcess | cellular response to growth hormone stimulus | 3.62e-06 | 27 | 81 | 4 | GO:0071378 | |
| GeneOntologyBiologicalProcess | regulation of hormone biosynthetic process | 1.18e-05 | 36 | 81 | 4 | GO:0046885 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid biosynthetic process | 1.47e-05 | 38 | 81 | 4 | GO:0010893 | |
| GeneOntologyBiologicalProcess | response to growth hormone | 2.00e-05 | 41 | 81 | 4 | GO:0060416 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid metabolic process | 2.21e-05 | 42 | 81 | 4 | GO:0045940 | |
| GeneOntologyBiologicalProcess | regulation of response to nutrient levels | 3.18e-05 | 46 | 81 | 4 | GO:0032107 | |
| GeneOntologyBiologicalProcess | positive regulation of multicellular organism growth | 3.46e-05 | 47 | 81 | 4 | GO:0040018 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 5.59e-05 | 104 | 81 | 5 | GO:0007405 | |
| GeneOntologyBiologicalProcess | response to food | 7.97e-05 | 58 | 81 | 4 | GO:0032094 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor signaling pathway via JAK-STAT | 7.97e-05 | 58 | 81 | 4 | GO:0046427 | |
| GeneOntologyBiologicalProcess | positive regulation of D-glucose transmembrane transport | 1.10e-04 | 63 | 81 | 4 | GO:0010828 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor signaling pathway via STAT | 1.25e-04 | 65 | 81 | 4 | GO:1904894 | |
| GeneOntologyBiologicalProcess | response to light stimulus | 1.27e-04 | 382 | 81 | 8 | GO:0009416 | |
| GeneOntologyBiologicalProcess | positive regulation of tyrosine phosphorylation of STAT protein | 1.57e-04 | 69 | 81 | 4 | GO:0042531 | |
| GeneOntologyBiologicalProcess | lung alveolus development | 2.17e-04 | 75 | 81 | 4 | GO:0048286 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 2.35e-04 | 418 | 81 | 8 | GO:0051962 | |
| GeneOntologyBiologicalProcess | D-glucose transmembrane transport | 2.94e-04 | 148 | 81 | 5 | GO:1904659 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 3.12e-04 | 233 | 81 | 6 | GO:0061351 | |
| GeneOntologyBiologicalProcess | hormone biosynthetic process | 3.20e-04 | 83 | 81 | 4 | GO:0042446 | |
| GeneOntologyBiologicalProcess | hexose transmembrane transport | 3.22e-04 | 151 | 81 | 5 | GO:0008645 | |
| GeneOntologyBiologicalProcess | regulation of tyrosine phosphorylation of STAT protein | 3.51e-04 | 85 | 81 | 4 | GO:0042509 | |
| GeneOntologyBiologicalProcess | monosaccharide transmembrane transport | 3.53e-04 | 154 | 81 | 5 | GO:0015749 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 3.84e-04 | 87 | 81 | 4 | GO:0033143 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to synapse | 4.20e-04 | 8 | 81 | 2 | GO:1902474 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle clustering | 4.20e-04 | 8 | 81 | 2 | GO:2000809 | |
| GeneOntologyBiologicalProcess | tyrosine phosphorylation of STAT protein | 4.36e-04 | 90 | 81 | 4 | GO:0007260 | |
| GeneOntologyBiologicalProcess | regulation of multicellular organism growth | 4.94e-04 | 93 | 81 | 4 | GO:0040014 | |
| GeneOntologyBiologicalProcess | carbohydrate transmembrane transport | 5.25e-04 | 168 | 81 | 5 | GO:0034219 | |
| GeneOntologyBiologicalProcess | terminal button organization | 5.39e-04 | 9 | 81 | 2 | GO:0072553 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 6.72e-04 | 10 | 81 | 2 | GO:0097105 | |
| GeneOntologyBiologicalProcess | positive regulation of inhibitory postsynaptic potential | 6.72e-04 | 10 | 81 | 2 | GO:0097151 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 6.88e-04 | 44 | 81 | 3 | GO:0098698 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 7.20e-04 | 273 | 81 | 6 | GO:0034764 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 7.60e-04 | 625 | 81 | 9 | GO:0051960 | |
| GeneOntologyBiologicalProcess | regulation of D-glucose transmembrane transport | 7.81e-04 | 105 | 81 | 4 | GO:0010827 | |
| GeneOntologyBiologicalProcess | response to radiation | 8.00e-04 | 503 | 81 | 8 | GO:0009314 | |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 8.09e-04 | 106 | 81 | 4 | GO:0050810 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 8.19e-04 | 11 | 81 | 2 | GO:0097104 | |
| GeneOntologyBiologicalProcess | carbohydrate transport | 8.32e-04 | 186 | 81 | 5 | GO:0008643 | |
| GeneOntologyBiologicalProcess | modulation of inhibitory postsynaptic potential | 9.80e-04 | 12 | 81 | 2 | GO:0098828 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle clustering | 9.80e-04 | 12 | 81 | 2 | GO:2000807 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-tyrosine phosphorylation | 9.82e-04 | 193 | 81 | 5 | GO:0050731 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 1.10e-03 | 198 | 81 | 5 | GO:0007259 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 1.16e-03 | 13 | 81 | 2 | GO:0097090 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid biosynthetic process | 1.32e-03 | 121 | 81 | 4 | GO:0046889 | |
| GeneOntologyBiologicalProcess | regulation of respiratory gaseous exchange by nervous system process | 1.34e-03 | 14 | 81 | 2 | GO:0002087 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system process | 1.47e-03 | 57 | 81 | 3 | GO:0031646 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | GH1 GH2 PIKFYVE CSH1 CSH2 CAMKV P3H3 CSNK1G2 ICAM1 TRPC6 PRMT3 | 1.47e-03 | 976 | 81 | 11 | GO:0018193 |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 1.49e-03 | 125 | 81 | 4 | GO:0046425 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 1.62e-03 | 216 | 81 | 5 | GO:0097696 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 1.76e-03 | 16 | 81 | 2 | GO:0007158 | |
| GeneOntologyCellularComponent | growth hormone receptor complex | 4.57e-09 | 6 | 89 | 4 | GO:0070195 | |
| GeneOntologyCellularComponent | endosome lumen | 3.34e-05 | 43 | 89 | 4 | GO:0031904 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 1.07e-04 | 4 | 89 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.25e-04 | 530 | 89 | 9 | GO:0062023 | |
| MousePheno | decreased pituitary gland weight | 3.13e-08 | 8 | 66 | 4 | MP:0008938 | |
| MousePheno | absent somatotrophs | 5.61e-08 | 9 | 66 | 4 | MP:0008330 | |
| MousePheno | absent lactotrophs | 5.61e-08 | 9 | 66 | 4 | MP:0008333 | |
| MousePheno | increased circulating ghrelin level | 2.18e-07 | 12 | 66 | 4 | MP:0011612 | |
| MousePheno | abnormal pituitary gland weight | 2.18e-07 | 12 | 66 | 4 | MP:0008937 | |
| MousePheno | abnormal circulating ghrelin level | 5.95e-07 | 15 | 66 | 4 | MP:0011611 | |
| MousePheno | decreased lactotroph cell number | 1.03e-06 | 17 | 66 | 4 | MP:0008332 | |
| MousePheno | abnormal lactotroph morphology | 1.67e-06 | 19 | 66 | 4 | MP:0008323 | |
| MousePheno | decreased somatotroph cell number | 2.55e-06 | 21 | 66 | 4 | MP:0008329 | |
| MousePheno | small adenohypophysis | 3.75e-06 | 23 | 66 | 4 | MP:0008321 | |
| MousePheno | abnormal somatotroph morphology | 4.49e-06 | 24 | 66 | 4 | MP:0008322 | |
| MousePheno | delayed vaginal opening | 8.52e-06 | 28 | 66 | 4 | MP:0002636 | |
| MousePheno | small pituitary gland | 1.13e-05 | 30 | 66 | 4 | MP:0005361 | |
| MousePheno | abnormal timing of vaginal opening | 1.30e-05 | 31 | 66 | 4 | MP:0020150 | |
| MousePheno | abnormal platelet morphology | GH1 GH2 PTP4A2 ABI3BP CSH1 CSH2 ASPM HSF2BP TRAPPC10 ATP13A3 PLD5 ZMYND12 | 2.06e-05 | 600 | 66 | 12 | MP:0004720 |
| MousePheno | abnormal pituitary gland size | 4.43e-05 | 42 | 66 | 4 | MP:0008936 | |
| MousePheno | increased brown adipose tissue amount | 4.87e-05 | 43 | 66 | 4 | MP:0000005 | |
| MousePheno | delayed sexual maturation | 8.18e-05 | 49 | 66 | 4 | MP:0001938 | |
| MousePheno | increased white adipose tissue amount | 1.03e-04 | 52 | 66 | 4 | MP:0000008 | |
| MousePheno | abnormal white adipose tissue morphology | 1.28e-04 | 321 | 66 | 8 | MP:0002970 | |
| MousePheno | disproportionate dwarf | 1.48e-04 | 57 | 66 | 4 | MP:0002427 | |
| MousePheno | decreased spleen weight | 1.91e-04 | 113 | 66 | 5 | MP:0004953 | |
| MousePheno | abnormal prepulse inhibition | 2.11e-04 | 542 | 66 | 10 | MP:0003088 | |
| MousePheno | decreased kidney weight | 2.62e-04 | 66 | 66 | 4 | MP:0003918 | |
| MousePheno | thrombocytopenia | 2.92e-04 | 273 | 66 | 7 | MP:0003179 | |
| MousePheno | abnormal sexual maturation | 4.07e-04 | 74 | 66 | 4 | MP:0001937 | |
| MousePheno | abnormal bone mineral content | GH1 GH2 AP4E1 CLPTM1L CSH1 CSH2 ANKUB1 TRAPPC10 PRMT3 ATP13A3 ANAPC7 | 4.64e-04 | 713 | 66 | 11 | MP:0010122 |
| MousePheno | abnormal white adipose tissue amount | 4.81e-04 | 138 | 66 | 5 | MP:0001781 | |
| MousePheno | abnormal platelet cell number | 5.37e-04 | 397 | 66 | 8 | MP:0011898 | |
| MousePheno | abnormal brown adipose tissue amount | 6.01e-04 | 82 | 66 | 4 | MP:0001778 | |
| MousePheno | decreased lean body mass | 6.32e-04 | 407 | 66 | 8 | MP:0003961 | |
| MousePheno | increased total body fat amount | 8.25e-04 | 424 | 66 | 8 | MP:0010024 | |
| MousePheno | abnormal secondary sex determination | 8.54e-04 | 90 | 66 | 4 | MP:0002212 | |
| MousePheno | abnormal adenohypophysis morphology | 9.27e-04 | 92 | 66 | 4 | MP:0004163 | |
| MousePheno | disorganized sperm mitochondrial sheath | 9.64e-04 | 10 | 66 | 2 | MP:0014468 | |
| MousePheno | abnormal glucose tolerance | GH1 GH2 AP4E1 FAM13A CSH1 CSH2 RBL1 APOL6 ATP13A3 RPL13A ANAPC7 | 1.05e-03 | 787 | 66 | 11 | MP:0005291 |
| MousePheno | decreased myeloid cell number | 1.31e-03 | 567 | 66 | 9 | MP:0013662 | |
| Domain | SOMATOTROPIN_2 | 5.95e-09 | 6 | 85 | 4 | PS00338 | |
| Domain | Hormone_1 | 5.95e-09 | 6 | 85 | 4 | PF00103 | |
| Domain | SOMATOTROPIN_1 | 5.95e-09 | 6 | 85 | 4 | PS00266 | |
| Domain | Somatotropin | 1.38e-08 | 7 | 85 | 4 | IPR001400 | |
| Domain | DUF1220 | 4.95e-08 | 9 | 85 | 4 | SM01148 | |
| Domain | NBPF_dom | 1.29e-07 | 11 | 85 | 4 | IPR010630 | |
| Domain | NBPF | 1.29e-07 | 11 | 85 | 4 | PS51316 | |
| Domain | DUF1220 | 1.29e-07 | 11 | 85 | 4 | PF06758 | |
| Domain | Somatotropin_CS | 9.04e-07 | 5 | 85 | 3 | IPR018116 | |
| Domain | 4_helix_cytokine_core | 8.48e-05 | 51 | 85 | 4 | IPR012351 | |
| Domain | TPR-like_helical_dom | 9.29e-05 | 233 | 85 | 7 | IPR011990 | |
| Domain | Nlgn | 2.03e-04 | 5 | 85 | 2 | IPR000460 | |
| Domain | 4_helix_cytokine-like_core | 3.61e-04 | 74 | 85 | 4 | IPR009079 | |
| Domain | - | 3.64e-04 | 207 | 85 | 6 | 1.25.40.10 | |
| Domain | TPR-contain_dom | 6.12e-04 | 150 | 85 | 5 | IPR013026 | |
| Domain | TPR_REGION | 9.40e-04 | 165 | 85 | 5 | PS50293 | |
| Domain | TPR | 9.40e-04 | 165 | 85 | 5 | PS50005 | |
| Domain | - | 1.53e-03 | 50 | 85 | 3 | 1.20.1250.10 | |
| Domain | Carboxylesterase_B_CS | 1.55e-03 | 13 | 85 | 2 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 1.80e-03 | 14 | 85 | 2 | PS00941 | |
| Domain | COesterase | 1.80e-03 | 14 | 85 | 2 | PF00135 | |
| Domain | CarbesteraseB | 1.80e-03 | 14 | 85 | 2 | IPR002018 | |
| Domain | TPR | 2.86e-03 | 129 | 85 | 4 | SM00028 | |
| Domain | TPR_repeat | 3.19e-03 | 133 | 85 | 4 | IPR019734 | |
| Domain | Myosin-like_IQ_dom | 3.33e-03 | 19 | 85 | 2 | IPR027401 | |
| Domain | - | 3.33e-03 | 19 | 85 | 2 | 4.10.270.10 | |
| Domain | IQ | 4.16e-03 | 71 | 85 | 3 | PF00612 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 9.43e-10 | 13 | 55 | 5 | MM14516 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 2.74e-07 | 15 | 55 | 4 | M552 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 3.64e-07 | 16 | 55 | 4 | MM15710 | |
| Pathway | BIOCARTA_LONGEVITY_PATHWAY | 7.70e-07 | 19 | 55 | 4 | MM1513 | |
| Pathway | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | 9.59e-07 | 20 | 55 | 4 | MM15070 | |
| Pathway | BIOCARTA_AKT_PATHWAY | 2.91e-06 | 26 | 55 | 4 | MM1345 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 4.58e-06 | 29 | 55 | 4 | MM1522 | |
| Pathway | BIOCARTA_GH_PATHWAY | 7.80e-06 | 33 | 55 | 4 | MM1404 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 1.07e-04 | 24 | 55 | 3 | M519 | |
| Pathway | REACTOME_PEPTIDE_HORMONE_METABOLISM | 1.57e-04 | 70 | 55 | 4 | MM14916 | |
| Pathway | WP_ADIPOGENESIS_GENES | 1.90e-04 | 137 | 55 | 5 | MM15970 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 3.10e-04 | 7 | 55 | 2 | M47646 | |
| Pathway | REACTOME_REGULATION_OF_APC_C_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE | 3.37e-04 | 35 | 55 | 3 | MM14689 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 6.41e-04 | 272 | 55 | 6 | M13380 | |
| Pubmed | 6.38e-14 | 21 | 89 | 7 | 16079250 | ||
| Pubmed | 4.01e-11 | 4 | 89 | 4 | 7169009 | ||
| Pubmed | Central growth hormone action regulates metabolism during pregnancy. | 2.00e-10 | 5 | 89 | 4 | 31479305 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 10767558 | ||
| Pubmed | Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. | 2.00e-10 | 5 | 89 | 4 | 8496314 | |
| Pubmed | Exploring endocrine GH pattern in mice using rank plot analysis and random blood samples. | 2.00e-10 | 5 | 89 | 4 | 21045135 | |
| Pubmed | Analysis of gender difference of cardiac risk biomarkers using hGH-transgenic mice. | 2.00e-10 | 5 | 89 | 4 | 16508206 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 18006625 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 15616010 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 19019400 | ||
| Pubmed | The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH? | 2.00e-10 | 5 | 89 | 4 | 32556100 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 1525063 | ||
| Pubmed | Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice. | 2.00e-10 | 5 | 89 | 4 | 11346667 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 12010633 | ||
| Pubmed | Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis. | 2.00e-10 | 5 | 89 | 4 | 17626886 | |
| Pubmed | Growth hormone prevents the development of autoimmune diabetes. | 2.00e-10 | 5 | 89 | 4 | 24218587 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 19359380 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 9546108 | ||
| Pubmed | Transgene transmission to progeny by oMt1a-oGH transgenic mice. | 2.00e-10 | 5 | 89 | 4 | 16201410 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 15316240 | ||
| Pubmed | Genes that prolong life: relationships of growth hormone and growth to aging and life span. | 2.00e-10 | 5 | 89 | 4 | 11487592 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 11318985 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 17301034 | ||
| Pubmed | Growth hormone action in the developing neural retina: a proteomic analysis. | 2.00e-10 | 5 | 89 | 4 | 18203262 | |
| Pubmed | Identification of the glomerular podocyte as a target for growth hormone action. | 2.00e-10 | 5 | 89 | 4 | 17272398 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 20707609 | ||
| Pubmed | Assignment of the porcine growth hormone gene to chromosome 12. | 2.00e-10 | 5 | 89 | 4 | 2249485 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 17242167 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 18180319 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 1874564 | ||
| Pubmed | Cloning and characterisation of the GH gene from the common dolphin (Delphinus delphis). | 2.00e-10 | 5 | 89 | 4 | 12225773 | |
| Pubmed | Growth Hormone Deficiency and Excess Alter the Gut Microbiome in Adult Male Mice. | 2.00e-10 | 5 | 89 | 4 | 32100023 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 3780533 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 10395045 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 24190208 | ||
| Pubmed | Brief report: short stature caused by a mutant growth hormone. | 2.00e-10 | 5 | 89 | 4 | 8552145 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 36762426 | ||
| Pubmed | High molecular weight isoforms of growth hormone in cells of the immune system. | 2.00e-10 | 5 | 89 | 4 | 21741628 | |
| Pubmed | Structure of the growth hormone-encoding gene and its promoter in mice. | 2.00e-10 | 5 | 89 | 4 | 8647448 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 26887678 | ||
| Pubmed | Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies. | 2.00e-10 | 5 | 89 | 4 | 10810296 | |
| Pubmed | The role of growth hormone in fetal mouse reproductive tract differentiation. | 2.00e-10 | 5 | 89 | 4 | 8756530 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 31099824 | ||
| Pubmed | Somatotropin transgenic mice have reduced jejunal active glucose transport rates. | 2.00e-10 | 5 | 89 | 4 | 7965203 | |
| Pubmed | Hot spots for growth hormone gene deletions in homologous regions outside of Alu repeats. | 2.00e-10 | 5 | 89 | 4 | 1980158 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 17881271 | ||
| Pubmed | Neural growth hormone implicated in body weight sex differences. | 2.00e-10 | 5 | 89 | 4 | 23861378 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 12759574 | ||
| Pubmed | Growth hormone production and action in N1E-115 neuroblastoma cells. | 2.00e-10 | 5 | 89 | 4 | 19301152 | |
| Pubmed | Adipocyte insensitivity to insulin in growth hormone-transgenic mice. | 2.00e-10 | 5 | 89 | 4 | 11350075 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 18617616 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 17347312 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 11570960 | ||
| Pubmed | Promoter shuffling has occurred during the evolution of the vertebrate growth hormone gene. | 2.00e-10 | 5 | 89 | 4 | 10974531 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 21852148 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 12175649 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 15070902 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 23428905 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 14726450 | ||
| Pubmed | UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences. | 2.00e-10 | 5 | 89 | 4 | 24758742 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 10076541 | ||
| Pubmed | Overgrowth of skin in growth hormone transgenic mice depends on the presence of male gonads. | 2.00e-10 | 5 | 89 | 4 | 10594738 | |
| Pubmed | Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes. | 2.00e-10 | 5 | 89 | 4 | 23639351 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 21098290 | ||
| Pubmed | Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH. | 2.00e-10 | 5 | 89 | 4 | 17761891 | |
| Pubmed | Age-related changes in body composition of bovine growth hormone transgenic mice. | 2.00e-10 | 5 | 89 | 4 | 18948397 | |
| Pubmed | The human growth hormone locus: nucleotide sequence, biology, and evolution. | 5.99e-10 | 6 | 89 | 4 | 2744760 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 12399427 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 14596666 | ||
| Pubmed | GH modulates hepatic epidermal growth factor signaling in the mouse. | 5.99e-10 | 6 | 89 | 4 | 20032199 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 11316754 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 11309401 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 23150490 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 2991252 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 25017732 | ||
| Pubmed | Third party data gene data set of eutherian growth hormone genes. | 5.99e-10 | 6 | 89 | 4 | 26697363 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 10689811 | ||
| Pubmed | Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse. | 5.99e-10 | 6 | 89 | 4 | 15985453 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 20863500 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 24949662 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 33539533 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 20231469 | ||
| Pubmed | Growth hormone resistance: clinical states and animal models. | 5.99e-10 | 6 | 89 | 4 | 10556764 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 12208853 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 9175714 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 16141391 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 18618017 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 12166626 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 9275086 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 23782652 | ||
| Pubmed | Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. | 5.99e-10 | 6 | 89 | 4 | 14759511 | |
| Pubmed | Age related changes in gene expression within the cochlea of C57BL/6J mice. | 5.99e-10 | 6 | 89 | 4 | 23010755 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 25645493 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 15166120 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 24691732 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 21725989 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 38951485 | ||
| Pubmed | Evidence that growth hormone exerts a feedback effect on stomach ghrelin production and secretion. | 5.99e-10 | 6 | 89 | 4 | 14530511 | |
| Pubmed | Growth hormone controls lipolysis by regulation of FSP27 expression. | 5.99e-10 | 6 | 89 | 4 | 30400015 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 26862561 | ||
| Cytoband | 17q24.2 | 3.48e-07 | 30 | 89 | 4 | 17q24.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 1.44e-05 | 404 | 89 | 7 | chr1q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 9.13e-05 | 120 | 89 | 4 | chr17q23 | |
| Cytoband | 1q21.1 | 2.45e-04 | 62 | 89 | 3 | 1q21.1 | |
| Cytoband | 11p15.3 | 7.62e-04 | 21 | 89 | 2 | 11p15.3 | |
| Cytoband | 4q22.1 | 1.17e-03 | 26 | 89 | 2 | 4q22.1 | |
| Cytoband | 22q12.3 | 1.89e-03 | 33 | 89 | 2 | 22q12.3 | |
| GeneFamily | Neuroblastoma breakpoint family | 1.46e-12 | 23 | 66 | 7 | 662 | |
| GeneFamily | Growth hormone family | 2.42e-09 | 6 | 66 | 4 | 1175 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 8.26e-04 | 115 | 66 | 4 | 769 | |
| GeneFamily | Anaphase promoting complex |Tetratricopeptide repeat domain containing | 1.16e-03 | 14 | 66 | 2 | 402 | |
| GeneFamily | Serpin peptidase inhibitors | 8.05e-03 | 37 | 66 | 2 | 739 | |
| GeneFamily | Cyclins|F-boxes other | 8.91e-03 | 39 | 66 | 2 | 560 | |
| GeneFamily | DEAD-box helicases | 1.03e-02 | 42 | 66 | 2 | 499 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 8.22e-08 | 182 | 89 | 7 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | Severe-B_intermediate-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.06e-07 | 126 | 89 | 6 | 42a0bdbe18ef85146cac4e86b2b27d0b3b20d8a2 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.34e-07 | 143 | 89 | 6 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.08e-06 | 167 | 89 | 6 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.05e-05 | 144 | 89 | 5 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | (00)_Basal|World / shred by cell type and Timepoint | 1.24e-05 | 149 | 89 | 5 | 49e39206f37cee124ca4763c79425b805e50624b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 160 | 89 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 160 | 89 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.40e-05 | 171 | 89 | 5 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 2.99e-05 | 179 | 89 | 5 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-IPC_like-IPCs|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.83e-05 | 198 | 89 | 5 | b3488e916fff9a4ff62eb897d3783c93296dbd65 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-iMON-iMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.83e-05 | 198 | 89 | 5 | e6dad9dea8cbd368b1b127572212cc913b909ffe | |
| ToppCell | nucseq-Immune-Immune_Myeloid-iMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.83e-05 | 198 | 89 | 5 | bf5806424be33790f78f1c160398046a8725e469 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-IPC_like|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.83e-05 | 198 | 89 | 5 | 6d99901d4df24eb3c5cca80afd9a81eb7ee8fcf1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-OPC_related|5w / Sample Type, Dataset, Time_group, and Cell type. | 5.06e-05 | 200 | 89 | 5 | b19a75d4f23e9685cbb6c6fa873d7726f27bd5f2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-OPC_related-Oligodendrocyte/OPC|5w / Sample Type, Dataset, Time_group, and Cell type. | 5.06e-05 | 200 | 89 | 5 | b99dc49b735430a5ac51159575b904020d861927 | |
| Disease | isolated growth hormone deficiency type II (implicated_via_orthology) | 3.05e-10 | 5 | 84 | 4 | DOID:0060872 (implicated_via_orthology) | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 2.12e-09 | 7 | 84 | 4 | DOID:0060870 (implicated_via_orthology) | |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 5.98e-08 | 14 | 84 | 4 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | osteoporosis (biomarker_via_orthology) | 4.30e-07 | 22 | 84 | 4 | DOID:11476 (biomarker_via_orthology) | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 4.07e-06 | 147 | 84 | 6 | DOID:9352 (biomarker_via_orthology) | |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 4.66e-06 | 39 | 84 | 4 | DOID:9744 (implicated_via_orthology) | |
| Disease | proteinuria (biomarker_via_orthology) | 3.55e-04 | 10 | 84 | 2 | DOID:576 (biomarker_via_orthology) | |
| Disease | Russell-Silver syndrome | 3.55e-04 | 10 | 84 | 2 | C0175693 | |
| Disease | gestational diabetes (is_marker_for) | 1.06e-03 | 17 | 84 | 2 | DOID:11714 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YQLLGYLQKGKSARS | 946 | Q14146 | |
| YLNQSGLVYDNIKKL | 481 | Q9N2K0 | |
| KLKNAYVLYYLAIVG | 141 | P30988 | |
| AAGKIIYNLRNTLKY | 166 | Q9BWW8 | |
| RLAAKGVKLENYYIQ | 76 | Q5FYB1 | |
| YRKLLYGVNEIAVKV | 186 | Q9H7F0 | |
| RCYALFLNLINKYQK | 516 | Q8NEN0 | |
| AKNGSLQIRYKLNKY | 1071 | Q9C0A0 | |
| LYLYARYKQVKVGNC | 66 | Q9BR61 | |
| TAYYKGNLVAVKRVN | 556 | P16066 | |
| AYRGYKVRQLIKQQS | 1811 | Q8IZT6 | |
| NLKYLGLKALTYVIQ | 351 | Q9UPM8 | |
| QRAYYQLKKLDLAAA | 161 | Q8IVL6 | |
| YSRALYLGAKAIQLN | 321 | Q9UJX3 | |
| VLYVKLRAGQLSYKE | 1696 | Q9H1A4 | |
| LNILALVYRDQNKYK | 256 | Q9NSK0 | |
| YYLRQQKILNNLKAF | 171 | O94952 | |
| QIGNLKKYYLLNAAS | 106 | Q9H649 | |
| KGKQLYTIARYLQRA | 741 | A4D1F6 | |
| AYKILNGRQKIAALY | 1886 | Q03001 | |
| RLGKNLYTNEYVAIK | 61 | P78368 | |
| LQVKQSYKVRLVLYG | 966 | Q8IY21 | |
| ALLKNYGLLYCFRKD | 181 | P0DML3 | |
| IKNQADGYLFDRYKL | 311 | Q5JST6 | |
| ILYGDFKQRYKVLNA | 716 | P13535 | |
| LRIKLYNKYVQGNAE | 141 | Q8IYA7 | |
| GNANYRYKLSLKVAE | 51 | Q8IXT1 | |
| LKADKLYLQGLLQYY | 636 | Q96JB1 | |
| FKLKRNIGYFILQTY | 236 | P47870 | |
| QLLQYVERYGKRLKA | 421 | Q96FC9 | |
| NLKSVNELIYKRGYG | 146 | P18124 | |
| IANEKVALQKALLYY | 801 | O94988 | |
| QLAGFLANRQKKYKY | 46 | Q3BBV0 | |
| AAFRLFKYGVQLYKN | 331 | Q14451 | |
| LNVLAFAALYYRKDK | 721 | Q9NZ94 | |
| AKILGVYRIGYKNSQ | 1911 | Q9Y2I7 | |
| LVQKSLYIQAKYQRL | 666 | A2AJT9 | |
| LKLENLVYYNRLKNS | 146 | Q8NCB2 | |
| YILYLKNNIEKYREG | 666 | P0C221 | |
| FYGYIKLINFIRLKN | 86 | O60678 | |
| LYLGYKNKKLRVNIN | 671 | Q13616 | |
| YCRNILYNFLKLPAK | 51 | O95395 | |
| YKQVLRNDAKNLYAA | 636 | Q6PD62 | |
| KRAAILNYTKGLYFQ | 101 | O75426 | |
| KIYVLGGRQSKYAVN | 176 | Q8IYD2 | |
| LKLANRLYGEKTYNF | 86 | P30740 | |
| AGLSTYLYNRQRKIK | 496 | P05362 | |
| ALLKNYGLLYCFRKD | 181 | P0DML2 | |
| AYRALQKLSRGNYKV | 556 | O95104 | |
| NYQPLKYTRLLAAKV | 301 | Q8NFZ4 | |
| NPILYNLISKKYRAA | 351 | O43193 | |
| SLYNVSINLKGLKYI | 236 | O75031 | |
| QEEYFALQLKKGRLY | 1566 | O75445 | |
| RLYGVYDNEKKLQLQ | 286 | Q8N7P1 | |
| QLAGFLANRQKKYKY | 46 | P0DPF3 | |
| QLAGFLANRQKKYKY | 46 | Q6P3W6 | |
| QLAGFLANRQKKYKY | 46 | Q86T75 | |
| QLAGFLANRQKKYKY | 46 | Q5TAG4 | |
| QLAGFLANRQKKYKY | 46 | Q8N660 | |
| QLAGFLANRQKKYKY | 46 | A0A087WUL8 | |
| FAVNRLKLAEILYYK | 456 | P28749 | |
| KNYKELELLRQVYYG | 551 | O43147 | |
| LYLLGYQNSFQNKKR | 6 | A0A1B0GTD5 | |
| YLKKRFGGERLQVYL | 131 | Q9NY91 | |
| KIVRKAGNLTNAYVY | 46 | Q8WVM0 | |
| GDAKNRYQRLYVKFL | 1636 | Q9ULL5 | |
| YIFAKKYQGSFILRL | 61 | Q5JPH6 | |
| PVLKYQKRVALYIAA | 186 | A6NFN9 | |
| KKTRNNGTLYAYIFL | 96 | Q96KA5 | |
| YLRGNYRKAVKLLNS | 261 | Q9H9A5 | |
| ALLKNYGLLYCFRKD | 181 | P01242 | |
| LATVKRYYRAGLLQK | 331 | Q4W5G0 | |
| INISGNFYRNKLKYL | 41 | P40429 | |
| NYKVVLLGKYNAQGL | 416 | Q8WU10 | |
| NRLFGEKTYLFLQKY | 106 | Q9UIV8 | |
| GAFNSKQLLYLEKYR | 136 | Q12974 | |
| NGRYKTKYRSLLFNL | 656 | Q6ZMY3 | |
| LINELYQGKLKDYVR | 296 | Q96K76 | |
| KQYRYIKLQNGLQAL | 111 | O43847 | |
| ALLKNYGLLYCFRKD | 181 | P01241 | |
| YQDLSKYKQRRLAGA | 501 | O00337 | |
| RNLGLLYIAKKNYEE | 176 | Q9H0C1 | |
| YKKGAEVILNYGRLR | 66 | Q9NRH1 | |
| KKFLELNQYRAALTY | 566 | P59923 | |
| TLGDNVKYYNLARIK | 571 | Q9Y210 | |
| QKAEIYLQGALKNYL | 496 | P48553 | |
| YYNLILKKAGQFLDN | 86 | Q9NYU1 | |
| YKKFVGVQLCNSLRY | 966 | Q7Z7G0 | |
| KGLRALQSYIQGKTY | 86 | Q9Y6I8 | |
| KYVFYLNGREINQLK | 211 | Q86W24 | |
| SAILYLGNVTYKKRA | 406 | Q13459 |